Hepatocyte-specific Ptpn6 deletion protects from obesity-linked hepatic insulin resistance

Diabetes

Volumn 61, Issue 8, 2012, Pages 1949-1958

  Xu, Elaine ^a,b   Charbonneau, Alexandre ^a,b   Rolland, Yannève ^a,b   Bellmann, Kerstin ^a,b   Pao, Lily ^c,g   Siminovitch, Katherine A ^d   Neel, Benjamin G ^c   Beauchemin, Nicole ^e,f   Marette, André ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f MCGILL UNIVERSITY   (Canada)

^g FIVE PRIME THERAPEUTICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C1; GLUCOSE; INSULIN; PROTEIN TYROSINE PHOSPHATASE SHP 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; INSULIN CLEARANCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; KNOCKOUT MOUSE; LIPID DIET; LIVER CELL; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; BLOOD GLUCOSE; DIET, HIGH-FAT; GENE DELETION; INSULIN; INSULIN RESISTANCE; LIVER; MICE; OBESITY; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6;

EID: 84864383688     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-1502     Document Type: Article

References (45)

1. Neel BG, Gu H, Pao L. SH2-domain-containing protein-tyrosine phosphatases. In Handbook of Cell Signaling. Dennis EA, Ed. Burlington, Academic Press, 2003, p. 707-728
2. Noguchi T, Matozaki T, Horita K, Fujioka Y, Kasuga M. Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation. Mol Cell Biol 1994;14:6674-6682 (Pubitemid 24299736)
3. Milarski KL, Saltiel AR. Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. J Biol Chem 1994;269:21239-21243 (Pubitemid 24266500)
4. Kharitonenkov A, Schnekenburger J, Chen Z, et al. Adapter function of protein-tyrosine phosphatase 1D in insulin receptor/insulin receptor substrate-1 interaction. J Biol Chem 1995;270:29189-29193
5. Ugi S, Maegawa H, Kashiwagi A, Adachi M, Olefsky JM, Kikkawa R. Expression of dominant negative mutant SHPTP2 attenuates phosphatidylinositol 3′-kinase activity via modulation of phosphorylation of insulin receptor substrate-1. J Biol Chem 1996;271:12595-12602
6. Yamauchi K, Milarski KL, Saltiel AR, Pessin JE. Protein-tyrosine- phosphatase SHPTP2 is a required positive effector for insulin downstream signaling. Proc Natl Acad Sci USA 1995;92:664-668
7. Maegawa H, Hasegawa M, Sugai S, et al. Expression of a dominant negative SHP-2 in transgenic mice induces insulin resistance. J Biol Chem 1999;274:30236-30243
8. Shen SH, Bastien L, Posner BI, Chrétien P. A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases. Nature 1991;352:736-739 (Pubitemid 21912421)
9. Matthews RJ, Bowne DB, Flores E, Thomas ML. Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences. Mol Cell Biol 1992;12:2396-2405
10. Plutzky J, Neel BG, Rosenberg RD. Isolation of a src homology 2-containing tyrosine phosphatase. Proc Natl Acad Sci USA 1992;89:1123-1127
11. Yi TL, Cleveland JL, Ihle JN. Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13. Mol Cell Biol 1992;12:836-846
12. Chen HE, Chang S, Trub T, Neel BG. Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 1996;16:3685-3697 (Pubitemid 26199888)
13. Klingmüller U, Lorenz U, Cantley LC, Neel BG, Lodish HF. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 1995;80:729-738
14. Tomic S, Greiser U, Lammers R, et al. Association of SH2 domain protein tyrosine phosphatases with the epidermal growth factor receptor in human tumor cells. Phosphatidic acid activates receptor dephosphorylation by PTP1C. J Biol Chem 1995;270:21277-21284
15. Ren L, Chen X, Luechapanichkul R, et al. Substrate specificity of protein tyrosine phosphatases 1B, RPTPa, SHP-1, and SHP-2. Biochemistry 2011;50:2339-2356
16. Imani F, Rager KJ, Catipovic B, Marsh DG. Interleukin-4 (IL-4) induces phosphatidylinositol 3-kinase (p85) dephosphorylation. Implications for the role of SHP-1 in the IL-4-induced signals in human B cells. J Biol Chem 1997;272:7927-7931 (Pubitemid 27137354)
17. Yu Z, Su L, Hoglinger O, Jaramillo ML, Banville D, Shen SH. SHP-1 associates with both platelet-derived growth factor receptor and the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem 1998;273:3687-3694 (Pubitemid 28109796)
18. Cuevas B, Lu Y, Watt S, et al. SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity. J Biol Chem 1999;274:27583-27589
19. Dubois MJ, Bergeron S, Kim HJ, et al. The SHP-1 protein tyrosine phosphatase negativelymodulates glucose homeostasis. Nat Med 2006;12:549-556
20. Poy MN, Yang Y, Rezaei K, et al. CEACAM1 regulates insulin clearance in liver. Nat Genet 2002;30:270-276
21. Huang S, Kaw M, Harris MT, et al. Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1. Bone 2010;46:1138-1145
22. Najjar SM, Yang Y, Fernström MA, et al. Insulin acutely decreases hepatic fatty acid synthase activity. Cell Metab 2005;2:43-53 (Pubitemid 43239824)
23. Xu E, Dubois MJ, Leung N, et al. Targeted disruption of carcinoembryonic antigen-related cell adhesion molecule 1 promotes diet-induced hepatic steatosis and insulin resistance. Endocrinology 2009;150:3503-3512
24. Lee SJ, Heinrich G, Fedorova L, et al. Development of nonalcoholic steatohepatitis in insulin-resistant liver-specific S503A carcinoembryonic antigen-related cell adhesion molecule 1 mutant mice. Gastroenterology 2008;135:2084-2095
25. DeAngelis AM, Heinrich G, Dai T, et al. Carcinoembryonic antigen-related cell adhesion molecule 1: a link between insulin and lipid metabolism. Diabetes 2008;57:2296-2303
26. Oriente F, Iovino S, Cabaro S, et al. Prep1 controls insulin glucoregulatory function in liver by transcriptional targeting of SHP1 tyrosine phosphatase. Diabetes 2011;60:138-147
27. Angata T, Kerr SC, Greaves DR, Varki NM, Crocker PR, Varki A. Cloning and characterization of human Siglec-11: a recently evolved signaling molecule that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia. J Biol Chem 2002;277:24466-24474 (Pubitemid 34951971)
28. Ruff SJ, Chen K, Cohen S. Peroxovanadate induces tyrosine phosphorylation of multiple signaling proteins in mouse liver and kidney. J Biol Chem 1997;272:1263-1267 (Pubitemid 27034626)
29. Pao LI, Lam KP, Henderson JM, et al. B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity. Immunity 2007;27:35-48 (Pubitemid 47089020)
30. Qiu W, Avramoglu RK, Dubé N, et al. Hepatic PTP-1B expression regulates the assembly and secretion of apolipoprotein B-containing lipoproteins: evidence from protein tyrosine phosphatase-1B overexpression, knockout, and RNAi studies. Diabetes 2004;53:3057-3066 (Pubitemid 39564479)
31. Huang W, Metlakunta A, Dedousis N, et al. Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance. Diabetes 2010;59:347-357
32. Charbonneau A, Marette A. Inducible nitric oxide synthase induction underlies lipid-induced hepatic insulin resistance in mice: potential role of tyrosine nitration of insulin signaling proteins. Diabetes 2010;59:861-871
33. Kishore P, Gabriely I, Cui MH, et al. Role of hepatic glycogen breakdown in defective counterregulation of hypoglycemia in intensively treated type 1 diabetes. Diabetes 2006;55:659-666 (Pubitemid 43343221)
34. Clementi AH, Gaudy AM, van Rooijen N, Pierce RH, Mooney RA. Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling. Biochim Biophys Acta 2009;1792:1062-1072
35. Lanthier N, Molendi-Coste O, Horsmans Y, van Rooijen N, Cani PD, Leclercq IA. Kupffer cell activation is a causal factor for hepatic insulin resistance. Am J Physiol Gastrointest Liver Physiol 2010;298:G107-G116
36. Wunderlich FT, Ströhle P, Könner AC, et al. Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action. Cell Metab 2010;12:237-249
37. Stienstra R, Saudale F, Duval C, et al. Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity. Hepatology 2010;51:511-522
38. Fiset A, Xu E, Bergeron S, et al. Compartmentalized CDK2 is connected with SHP-1 and b-catenin and regulates insulin internalization. Cell Signal 2011;23:911-919
39. Michael MD, Kulkarni RN, Postic C, et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 2000;6:87-97
40. Kulkarni RN, Jhala US, Winnay JN, Krajewski S, Montminy M, Kahn CR. PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance. J Clin Invest 2004;114:828-836 (Pubitemid 39578742)
41. Okada T, Liew CW, Hu J, et al. Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance. Proc Natl Acad Sci USA 2007;104:8977-8982 (Pubitemid 47175422)
42. Escribano O, Guillén C, Nevado C, Gómez-Hernández A, Kahn CR, Benito M. b-Cell hyperplasia induced by hepatic insulin resistance: role of a liverpancreas endocrine axis through insulin receptor A isoform. Diabetes 2009;58:820-828
43. El Ouaamari A, Kawamori K, Liew CW, et al. Liver-derived factor(s) drive b-cell hyperplasia in insulin resistant mice. Late-breaking abstract presented at the 71st Scientific Sessions of the American Diabetes Association 24-28 June 2011, at the San Diego Convention Center, San Diego, California
44. Elchebly M, Payette P, Michaliszyn E, et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 1999;283:1544-1548
45. Delibegovic M, Zimmer D, Kauffman C, et al. Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress. Diabetes 2009;58:590-599